연구동향 분석
박사

골모세포 분화와 골형성 과정에서 CUEDC2 역할 = Role of CUEDC2 in osteoblast differentiation and bone formation

김정우 2019년

논문상세정보
인용/피인용
' 골모세포 분화와 골형성 과정에서 CUEDC2 역할 = Role of CUEDC2 in osteoblast differentiation and bone formation' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의료과학 약
  • Bone formation
  • CUEDC2
  • Osteoblast differentiation
  • stat3
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
432 0

0.0%

' 골모세포 분화와 골형성 과정에서 CUEDC2 역할 = Role of CUEDC2 in osteoblast differentiation and bone formation' 의 참고문헌

  • Zhang, W.N., L. Wang, Q. Wang, et al. CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling. J Biol Chem. 287, 382-92 (2012).
  • Zhang, P.J., J. Zhao, H.Y. Li, et al. CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin–proteasome. EMBO J. 26, 1831-42 (2007).
  • Yoshida, K., Y. Sumita, E. Marukawa, et al. Effect of platelet-rich plasma on bone engineering with an alloplastic substitute containing BMP2. Biomed Mater Eng. 23, 163-72 (2013).
  • Yanagisawa, M., K. Nakashima, and T. Taga. STAT3-mediated astrocyte differentiation from mouse fetal neuroepithelial cells by mouse oncostatin M. Neurosci Lett. 269, 169-72 (1999).
  • Yamaguchi, A., T. Ishizuya, N. Kintou, et al. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun. 220, 366-71 (1996).
  • Wu, Q.Y., Y.Y. Zhu, Y. Liu, et al. CUEDC2, a novel interacting partner of the SOCS1 protein, plays important roles in the leukaemogenesis of acute myeloid leukaemia. Cell Death Dis. 9, 774 (2018).
  • Wozney, J.M., V. Rosen, A.J. Celeste, et al. Novel regulators of bone formation: molecular clones and activities. Science. 242, 1528-34 (1988).
  • Vashishth, D., G. Gibson, J. Kimura, et al. Determination of bone volume by osteocyte population. Anat Rec. 267, 292-95 (2002).
  • Urist, M.R. Bone: formation by autoinduction. Science. 150, 893-99 (1965).
  • Song, L., D. Liu, Y. Zhao, et al. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis. Biochem Biophys Res Commun. 464, 705-10 (2015).
  • Shih, S.C., G. Prag, S.A. Francis, et al. A ubiquitin‐binding motif required for intramolecular monoubiquitylation, the CUE domain. EMBO J. 22, 1273-81 (2003).
  • Seo, B.B., J.T. Koh, and S.C. Song. Tuning physical properties and BMP-2 release rates of injectable hydrogel systems for an optimal bone regeneration effect. Biomaterials. 122, 91-104 (2017).
  • Pan, X., T. Zhou, Y.H. Tai, et al. Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer. Nat Med. 17, 708-14 (2011).
  • Orian, A., H. Gonen, B. Bercovich, et al. SCFβ‐TrCP ubiquitin ligase‐mediated processing of NF‐κB p 105 requires phosphorylation of its C‐terminus by IκB kinase. EMBO J. 19, 2580-91 (2000).
  • Ogata, T., J.M. Wozney, R. Benezra, et al. Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc Natl Acad Sci USA. 90, 9219-22 (1993).
  • Neto, A. and J. Ferreira. Synthetic and Marine-Derived Porous Scaffolds for Bone Tissue Engineering. Materials. 11, 1702 (2018).
  • Nakashima, K., X. Zhou, G. Kunkel, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 108, 17-29 (2002).
  • Murakami, T., A. Saito, S.i. Hino, et al. Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formation. Nat Cell Biol. 11, 1205-11 (2009).
  • Miyazono, K., S. Maeda, and T. Imamura. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16, 251-63 (2005).
  • Man, J. and X. Zhang. CUEDC2: an emerging key player in inflammation and tumorigenesis. Protein Cell. 2, 699-703 (2011).
  • Li, Q. and I.M. Verma. NF-κB regulation in the immune system. Nat Rev Immunol. 2, 725-34 (2002).
  • Li, J. JAK-STAT and bone metabolism. JakStat. 2, e23930 (2013).
  • Li, H.Y., H. Liu, C.H. Wang, et al. Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1. Nat Immunol. 9, 533-41 (2008).
  • Levy, J.B., C. Schindler, R. Raz, et al. Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells. Endocrinology. 137, 1159-65 (1996).
  • Komori, T., H. Yagi, S. Nomura, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89, 755-64 (1997).
  • Jonason, J., G. Xiao, M. Zhang, et al. Post-translational regulation of Runx2 in bone and cartilage. J Dent Res. 88, 693-703 (2009).
  • Jing, N. and D.J. Tweardy. Targeting Stat3 in cancer therapy. Anticancer Drugs. 16, 601-07 (2005).
  • Jiang, Y., B.N. Jahagirdar, R.L. Reinhardt, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 418, 41-9 (2002).
  • Jian, Z., B. Liang, X. Pan, et al. CUEDC2 modulates cardiomyocyte oxidative capacity by regulating GPX1 stability. EMBO Mol Med. 8, 813-29 (2016).
  • Itoh, S., N. Udagawa, N. Takahashi, et al. A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. Bone. 39, 505-12 (2006).
  • Hruska, K.A., S. Mathew, and G. Saab. Bone morphogenetic proteins in vascular calcification. Circ Res. 97, 105-14 (2005).
  • Heldin, C.H., K. Miyazono, and P. Ten Dijke. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature. 390, 465-71 (1997).
  • Hanisch, O., R.G. Sorensen, A. Kinoshita, et al. Effect of recombinant human bone morphogenetic protein‐2 in dehiscence defects with non‐submerged immediate implants: an experimental study in Cynomolgus monkeys. J periodontol. 74, 648-57 (2003).
  • Franceschi, R.T., G. Xiao, D. Jiang, et al. Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation. Connect Tissue Res. 44, 109-16 (2003).
  • Darnell, J.E. STATs and gene regulation. Science. 277, 1630-35 (1997).
  • Cooper, C., G. Campion, and L.r. Melton. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 2, 285-89 (1992).
  • Chen, Y., S.X. Wang, R. Mu, et al. Dysregulation of the miR-324-5p-CUEDC2 axis leads to macrophage dysfunction and is associated with colon cancer. Cell Rep. 7, 1982-93 (2014).
  • Chen, Y., J. Ouyang, J. L. Chen, et al. Silencing Socs3 markedly deteriorates spondyloarthritis in mice induced by minicricle DNA expressing IL23. Front Immunol. 9:2641 (2018).
  • Chang, J., Z. Wang, E. Tang, et al. Inhibition of osteoblastic bone formation by nuclear factor-κB. Nat Med. 15, 682-89 (2009).
  • Celeste, A.J., J.A. Iannazzi, R.C. Taylor, et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA. 87, 9843-47 (1990).
  • Abe, T., S. Nomura, R. Nakagawa, et al. Osteoblast differentiation is impaired in SOCS-1-deficient mice. J Bone Miner Metab. 24, 283-90 (2006).